Abstract:MicroRNAs (miRNAs) constitute a family of small non-coding ribonucleic acids that are post-transcriptional regulators of messenger RNA (mRNA) complexity. While miRNAs are known to be dynamically regulated during CNS development, the roles of specific miRNAs in CNS aging and neurodegeneration are not well understood. This study examined miRNA abundance and signaling circuitry in Alzheimer's disease (AD) brain, in cytokine-, Aβ42- and ROS-stressed human neural primary cell lines and in Tg2576 transgenic mice fed a high-fat cholesterol (HFC) diet. AD and age-matched control post-mortem brain tissue; IL-1β, Aβ42 and ROS-stressed human neural (HN) cells in primary culture; high-fat cholesterol (HFC) diet stressed Tg2576 mice; total DNA, RNA and protein isolation and quality control; DNA arrays (Affymetrix, Santa Clara, CA); micro RNA (miRNA) arrays (LC Sciences, Houston, TX); miRNA panels; Northern analysis; RT-PCR; Western Immunoblotting; gel shift assay; miRNA construct transfection vectors; specific NF–κB and inflammatory transcription factor repression; bioinformatics (Sanger miRBASE, Cambridge UK). Of the total number of miRNAs expressed in the human brain, only a selective subset appear to be altered in the AD process. miRNAs encoding miR-9, miR-124a, miR-125b, miR-128, miR-132 and miR-219 were found to be abundantly represented in fetal hippocampus however they exhibited differential regulation in Alzheimer hippocampus. Specific increases in the abundance of miRNA-146a was found to coincide with down-regulation in the abundance of one prominent miRNA-146a target, complement factor H (CFH) mRNA, encoding an important regulatory glycoprotein in the brain's complement and inflammatory response. Promoter mapping, inhibitor studies and transfection-reporter studies showed that miRNA-146a is an NF–κB-sensitive gene. We also observed a specific up-regulation of miRNA-146a in cytokine IL-1β- and Aβ42-stressed human neural cells and in HFC-stressed Tg2576 mice, an effect that was reversed in part by the cholesterol biosynthesis inhibitor simvastatin. These data are consistent with the idea that altered miRNA-mediated processing of mRNA populations may contribute to atypical mRNA abundance, neural dysfunction and inflammatory signaling pathways in Alzheimer's disease. The use of anti-miRNA pharmacotherapeutic strategies are attractive because they have potential to silence entire families of pro-inflammatory pathogenic genes in Alzheimer's disease brain. Supported in part by NIA AG18031.

Loss of miR-369 Promotes Tau Phosphorylation by Targeting the Fyn and Serine/Threonine-Protein Kinase 2 Signaling Pathways in Alzheimer’s Disease Mice

Down‐regulated Expression of Microrna‐338‐5p Contributes to Neuropathology in Alzheimer's Disease

MicroRNA-139 Modulates Alzheimer's-associated Pathogenesis in SAMP8 Mice by Targeting Cannabinoid Receptor Type 2.

MicroRNA‐128 Suppresses Tau Phosphorylation and Reduces Amyloid‐beta Accumulation by Inhibiting the Expression of GSK3β, APPBP2, and Mtor in Alzheimer's Disease

Genome-wide Analysis of Mirna Signature in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease.

MiR-124-3p Attenuates Hyperphosphorylation of Tau Protein-Induced Apoptosis Via Caveolin-1-pi3k/akt/gsk3β Pathway in N2a/APP695swe Cells

O3‐01‐05: MIR‐204 ATTENUATES MEMORY DEFICITS IN A MOUSE MODEL OF ALZHEIMER'S DISEASE

miR-146a-5p Modulates Adult Hippocampal Neurogenesis Deficits Through Klf4/p-Stat3 Signaling in APP/PS1 Mice

Human microRNA-153-3p targets specific neuronal genes and is associated with the risk of Alzheimer's disease.

Candidate Alzheimer’s Disease Biomarker miR-483-5p Lowers TAU Phosphorylation by Direct ERK1/2 Repression

miR-204-3p/Nox4 Mediates Memory Deficits in a Mouse Model of Alzheimer's Disease

Microrna-34A (Mirna-34A) Mediated Down-Regulation of the Post-synaptic Cytoskeletal Element SHANK3 in Sporadic Alzheimer's Disease (AD)

miR-204-3p/Nox4 Mediates Memory Deficits in a Mouse Model of Alzheimer's Disease.

MicroRNA-425-5p promotes tau phosphorylation and cell apoptosis in Alzheimer’s disease by targeting heat shock protein B8

The Role of MicroRNAs in Aβ Deposition and Tau Phosphorylation in Alzheimer’s Disease

miRNA375-3p/rapamycin mediates the mTOR pathway by decreasing PS1, enhances microglial cell activity to regulate autophagy in Alzheimer's disease

MiR-431 attenuates synaptic plasticity and memory deficits in APPswe/PS1dE9 mice

Elevated Levels of miR-144-3p Induce Cholinergic Degeneration by Impairing the Maturation of NGF in Alzheimer’s Disease

MicroRNA-668-3p regulates oxidative stress and cell damage induced by Aβ1-42 by targeting the OXR1/p53-p21 axis

O2-03-06: Micro RNA-146A–mediated Signaling in Alzheimer's Disease

Sponging of mirna-146a using aav-anti-mirna-146a-vectors mediates synaptic and amyloidogenic neuropathology and cognitive deficits in a 5xfad murine model of alzheimer’s disease